Biohaven

Biohaven is a uniquely different pharmaceutical company. People are at the center of all we do.

We're an agile and resilient team of highly skilled professionals who eagerly challenge the status quo to advance novel, life-changing therapies.

04/30/2026

Epilepsy isn’t rare. It impacts millions globally. Awareness brings support, understanding and the ability to advance research.
Biohaven’s investigational treatment targets specific potassium channels in the brain, aiming to help people with epilepsy reduce seizures.

04/23/2026

IgA Nephropathy (IgAN) doesn’t affect everyone equally. Certain minority populations, particularly Asian/Pacific Islander and Hispanic/Latino communities, experience higher incidence, faster disease progression and greater risk of end-stage kidney disease.
Awareness and early detection are key to improving outcomes for these communities. Biohaven is committed to advancing research and developing treatments for IgAN, with a focus on equity, access and patient-centered care.

04/19/2026

This World Liver Day, it’s worth remembering that the liver isn’t just vital to metabolism, it’s also one of the body’s most powerful natural clearance systems. At Biohaven, our degrader programs are designed to work with the body by leveraging the liver’s inherent ability to remove harmful proteins and antibodies from circulation. By harnessing this natural biology, we aim to pursue more targeted approaches to treating immune-mediated disease.

04/16/2026

Living with Graves’ disease can mean navigating symptoms that impact daily life in unexpected ways. For Paige, the journey began with severe digestive issues and progressed to lightheadedness, intense fatigue, tremors and difficulty with everyday activities like climbing stairs. Hear her full story at: https://brnw.ch/21x1EsE

04/08/2026

We asked our employees what the most rewarding part of their job is. The answer? Knowing that their work matters to patients, families and the colleagues they mentor.

04/06/2026

Parkinson’s disease affects millions of people worldwide, yet many questions remain about how the disease begins and progresses.
Emerging research suggests that brain inflammation may play an important role. We are studying an investigational therapy designed to target the JAK/STAT pathway to better understand its potential role in Parkinson’s disease. This Parkinson’s Awareness Month, we recognize the importance of continued research to help advance the science forward. Learn more about our clinical trial: https://brnw.ch/21x1lZy

03/25/2026

“IT CAN MAKE YOU FEEL ALONE.”
David’s story is a reminder that is more than what people see, it affects daily life in ways many don’t realize. On Epilepsy Awareness Day, we thank him for sharing his story and helping shine a light on the realities of living with this disorder.
Learn more about our research: https://bit.ly/3PE2y9u

03/24/2026

Courtnay shares how her Graves’ disease diagnosis at a young age impacted her beyond the physical symptoms. It led to isolation, anxiety and a loss of confidence. Her story emphasizes the emotional toll of living with a chronic condition and reminds us why awareness and understanding matter. Hear more stories: https://brnw.ch/21x10k0

03/23/2026

We’re looking forward to being part of the upcoming Purple Day® Expo! On March 28, the epilepsy community will gather at Disney’s Coronado Springs Resort to share stories, resources and support for everyone impacted by epilepsy and Biohaven is proud to be there alongside them.
Join us: https://brnw.ch/21x0YqN

03/17/2026

March is , and we’re shining a light on IgA nephropathy (IgAN), a progressive kidney disease caused by the body’s immune system attacking itself. IgAN can lead to kidney damage and impact daily life, highlighting the urgent
need for new, targeted treatments. Every patient’s journey is unique, but understanding the disease is the first step toward hope.

03/12/2026

reminds us of the critical role kidneys play in overall health and the urgent need for new treatments for diseases like IgA nephropathy (IgAN).This progressive kidney disease can lead to renal failure within 10 to 15 years, affecting daily life, energy, and overall health. We are committed to advancing science that targets the root cause of IgAN and improving outcomes for patients living with this disease.

Learn more at: https://brnw.ch/21x0G7B

03/09/2026

This Brain Awareness Week, we’re highlighting Parkinson’s disease as a growing public ealth challenge affecting millions worldwide. We are committed to advancing research that addresses the root drivers of this devastating disease. Neuroinflammation plays a key role in disease progression, and our investigational therapy is designed to target this pathway. Through bold science and patientfocused innovation, we are working to change the trajectory of this disease. Learn more about our work in Parkinson’s: https://brnw.ch/21x0AGs

Address

215 Church Street
New Haven, CT
06510

Website

https://www.biohaven.com/

Alerts

Be the first to know and let us send you an email when Biohaven posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in New Haven?

PATIENT-FOCUSED, ADDRESSING UNMET MEDICAL NEEDS

Brain diseases are often chronic, incurable and represent an enormous burden to patients, families, and society. At Biohaven, we are committed to improving the lives of patients suffering from central nervous system disorders by advancing first-in-class and best-in-class therapies. - Vlad Coric, MD, CEO